96723-72-7

Basic information

• Product Name: 2-ARG-OBZL(4-NO2)HYDROCHLORIDE AND HYDROBROMIDE
• Synonyms: Z-ARG-P-NITROBENZYL ESTER;Z-ARG-OBZL(4-NO2) HCL AND HBR;2-ARG-OBZL(4-NO2)HYDROCHLORIDE AND HYDROBROMIDE;2-Arg-obzl(4-no2)HCl and HBr
• CAS NO: 96723-72-7
• Molecular Formula: C21H27BrClN5O6
• Molecular Weight: 560.83
• Mol File: 96723-72-7.mol

Chemical Properties

• Appearance: /
• Storage Temp.: Store at RT.
• CAS DataBase Reference: 2-ARG-OBZL(4-NO2)HYDROCHLORIDE AND HYDROBROMIDE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-ARG-OBZL(4-NO2)HYDROCHLORIDE AND HYDROBROMIDE(96723-72-7)
• EPA Substance Registry System: 2-ARG-OBZL(4-NO2)HYDROCHLORIDE AND HYDROBROMIDE(96723-72-7)

Safety Data

• Hazardous Substances Data: 96723-72-7(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Research:
2-ARG-OBZL(4-NO2)HYDROCHLORIDE AND HYDROBROMIDE are used as research tools for studying the endocannabinoid system in the brain. Their ability to inhibit FAAH and increase anandamide levels makes them valuable in understanding the system's role in various physiological and pathological processes.
Used in Pain Management:
In the field of pain management, 2-ARG-OBZL(4-NO2)HYDROCHLORIDE AND HYDROBROMIDE are used as potential therapeutic agents for treating pain conditions. Their mechanism of action involves enhancing the endocannabinoid system's natural pain-relieving properties.
Used in Anxiety Treatment:
2-ARG-OBZL(4-NO2)HYDROCHLORIDE AND HYDROBROMIDE are utilized in anxiety treatment research, exploring their potential to alleviate anxiety symptoms by modulating the endocannabinoid system, which is known to influence mood and emotional regulation.
Used in Anti-Inflammatory Applications:
In anti-inflammatory research, these compounds are studied for their capacity to reduce inflammation. By inhibiting FAAH, they may help in managing inflammatory conditions by leveraging the endocannabinoid system's anti-inflammatory effects.
Used in Drug Development:
2-ARG-OBZL(4-NO2)HYDROCHLORIDE AND HYDROBROMIDE are employed in drug development for the potential creation of new therapeutics targeting the endocannabinoid system. Their demonstrated efficacy in preclinical studies positions them as promising candidates for further development into treatments for various conditions.